-
Adefovir (GS-0393): HBV Mechanism and Research Use
2026-09-17
Adefovir, also known as GS-0393, is an acyclic nucleoside phosphonate used to study HBV DNA polymerase inhibition and renal OAT1 transport. Its research value depends on separating antiviral assay exposure from clinical pharmacokinetics and monitoring renal phosphate-wasting risk.
-
Carvedilol Phosphate in Hepatic IRI Research
2026-09-17
Carvedilol Phosphate is a non-selective beta blocker research reagent with additional alpha-1 adrenergic activity and defined formulation parameters. It is useful for cardiovascular pharmacology research and hypothesis-driven ischemia-reperfusion injury model design, but the cited hepatic study does not establish carvedilol as a treatment for liver IRI.
-
Cdc42–GSK-3β Signaling in Kidney Fibrosis
2026-09-16
The 2024 Advanced Science study identifies daphnepedunin A, a natural daphne diterpenoid, as an anti-fibrotic lead that targets Cdc42 and suppresses downstream GSK-3β/β-catenin signaling. Its combination of bioassay-guided chemistry, thermal proteome profiling, renal fibroblast assays, and unilateral ureteral obstruction models provides a mechanistic framework for evaluating Cdc42 as a kidney-fibrosis target.
-
SN-38 Disrupts FUBP1–FUSE DNA Binding
2026-09-15
The reference study identifies a mechanism beyond canonical topoisomerase I poisoning: camptothecin and its active metabolite SN-38 interfere with binding of the oncogenic transcriptional regulator FUBP1 to the single-stranded DNA element FUSE. Biochemical and cellular experiments suggest that this disruption can deregulate FUBP1-controlled genes in hepatocellular carcinoma, providing a framework for studying how SN-38 activity may depend on tumor transcriptional programs.
-
C34 TLR4 Inhibitor: Practical Assay Guide
2026-09-15
C34 is a selective TLR4 inhibitor for separating TLR4-driven inflammation from broader cytokine suppression in macrophage, enterocyte, tissue, and microglial assays. This workflow-focused guide covers dosing, controls, cross-model interpretation, and troubleshooting for inflammatory signaling research.
-
L-Alanyl-L-Glutamine: Assay Workflow Guide
2026-09-14
This scenario-based guide explains how L-Alanyl-L-Glutamine, SKU B8228, can help researchers standardize aqueous nutrient conditions in cell viability, proliferation, and cytotoxicity workflows. It covers solvent compatibility, stock preparation, controls, interpretation, and practical vendor-selection criteria without assuming that a nutritional supplement will directly improve every assay.
-
Humanized Gs-DREADD for Circuit Modulation
2026-09-14
Zhang et al. developed hM3Ds, a whole-sequence-humanized Gs-coupled DREADD designed to retain the activity profile of rM3Ds while reducing concerns associated with a non-human receptor backbone. In mouse experiments, selective hM3Ds expression in D1 medium spiny neurons activated the basal ganglia direct pathway and improved Parkinsonian phenotypes, supporting its value as a research tool while leaving clinical safety questions open.
-
FOXM1–ERα Networks in Female Lung Adenocarcinoma
2026-09-13
This reference preprint integrates transcriptomic, survival, immune, and ceRNA analyses to investigate FOXM1 in female lung adenocarcinoma. Its main contribution is a testable connection among FOXM1, miR-204-5p, and estrogen receptor signaling, although the proposed network remains only partially validated.
-
Phenothiazines, ROS, and Macrophage Antibacterial Defense
2026-09-12
The 2025 reference study identifies phenothiazines as host-directed antibacterial leads that enhance macrophage activity through reactive oxygen species accumulation, lysosomal activation, and autophagy. Its inhibitor and scavenger experiments support a functional role for these pathways, while an in vivo perphenazine model links the mechanism to reduced lesions and inflammation during Salmonella Typhimurium infection.
-
Sulfo-Cy5 NHS Ester: Aqueous Labeling Guide
2026-09-12
Sulfo-Cy5 NHS ester, also called Sulfo-Cyanine5 Succinimidyl Ester, is an amine-reactive fluorescent probe for aqueous biomolecule labeling. Its far-red spectral profile, sulfonated structure, and product-documented LLP2A imaging use support protein conjugation for fluorescence imaging, while storage and solid-state solubility require careful control.
-
Direct Mouse Genotyping Kit: Practical PCR Workflow
2026-09-11
The Direct Mouse Genotyping Kit streamlines genomic DNA release and PCR amplification from mouse tissue by combining direct lysis with a ready-to-use PCR master mix with dye. It is suited to routine mouse genetic screening and high-throughput genotyping, but direct lysates should not be treated as purified DNA or assumed to support every tissue type, assay format, or downstream application.
-
Cyclophilin A and Cyclosporin Immunosuppression
2026-09-11
The reference study used Ppia-targeted genetics to show that Cyclophilin A is the principal intracellular mediator of Cyclosporin immunosuppression in T cells and mice. Its combination of cellular signaling assays, allogeneic challenge, and adoptive reconstitution provides a causal framework for interpreting calcineurin inhibition and designing mechanistic immunosuppression experiments.
-
Trilaurin Workflows for Biocatalysis and Drug Delivery
2026-09-10
Trilaurin connects renewable-feedstock biocatalysis with lipid-based delivery systems, from laurylamine synthesis to oral protection of peptide and protein payloads. This practical guide covers assay setup, formulation choices, scale-up benchmarks, and troubleshooting for more reproducible bench workflows.
-
Rotigotine Hydrochloride in Translational PD
2026-09-10
Rotigotine hydrochloride is more than a conventional dopaminergic tool. Its D2/D3 agonism, broader receptor activity, transdermal clinical history, and analytical liabilities create a strategic framework for designing more reproducible Parkinson’s disease research and translational studies.
-
ECE-1c Stability, CK2, and Cisplatin Resistance
2026-09-09
The 2024 study identifies a non-canonical mechanism in which the K6R variant of ECE-1c promotes stemness, cisplatin resistance, and invasion in non-small cell lung cancer cells without increasing short-term ET-1 secretion. Its findings connect CK2-dependent ECE-1c regulation with cancer aggressiveness and support Silmitasertib as a mechanistic tool for testing this pathway, while highlighting the need for in vivo and clinical validation.